The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Initial report of RTOG 9601, a phase III trial in prostate cancer: Effect of anti-androgen therapy (AAT) with bicalutamide during and after radiation therapy (RT) on freedom from progression and incidence of metastatic disease in patients following radical prostatectomy (RP) with pT2-3,N0 disease and elevated PSA levels.
William U. Shipley
No relevant relationships to disclose
Daniel Hunt
No relevant relationships to disclose
Himu R. Lukka
No relevant relationships to disclose
Pierre Major
No relevant relationships to disclose
Niall M. Heney
No relevant relationships to disclose
David Grignon
No relevant relationships to disclose
Maltibehn Patel
No relevant relationships to disclose
Jean-Paul Bahary
No relevant relationships to disclose
Colleen Anne Lawton
No relevant relationships to disclose
Howard Mark Sandler
No relevant relationships to disclose